{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:24:36Z","timestamp":1768011876102,"version":"3.49.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T00:00:00Z","timestamp":1629590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T00:00:00Z","timestamp":1629590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00277-021-04645-2","type":"journal-article","created":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T09:02:25Z","timestamp":1629622945000},"page":"2849-2850","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Iguratimod triggers the relapse of methotrexate-associated lymphoproliferative disorder"],"prefix":"10.1007","volume":"100","author":[{"given":"Hiroaki","family":"Nagata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kodai","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneo","family":"Ohshiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Yamamoto-Sugitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Fujimoto-Hirakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoji","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6130-1550","authenticated-orcid":false,"given":"Junya","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,22]]},"reference":[{"key":"4645_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109704","volume":"122","author":"H Jiang","year":"2020","unstructured":"Jiang H, Gao H, Wang Q, Wang M, Wu B (2020) Molecular mechanisms and clinical application of Iguratimod: a review. Biomed Pharmacother 122:109704. https:\/\/doi.org\/10.1016\/j.biopha.2019.109704","journal-title":"Biomed Pharmacother"},{"key":"4645_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3960\/jslrt.19007","volume":"59","author":"M Tokuhira","year":"2019","unstructured":"Tokuhira M, Tamaru J, Kizaki M (2019) Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders. J Clin Exp Hematop 59:72\u201392. https:\/\/doi.org\/10.3960\/jslrt.19007","journal-title":"J Clin Exp Hematop"},{"key":"4645_CR3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3109\/10428194.2014.928936","volume":"56","author":"S Maegawa","year":"2015","unstructured":"Maegawa S, Kuroda J, Kobayashi T, Fuchida S, Kawata E, Kamitsuji Y et al (2015) Clinical manifestation and prognostic factors of 32 Japanese patients with autoimmune disease-associated diffuse large B-cell lymphoma. Leuk Lymphoma 56:785\u2013788. https:\/\/doi.org\/10.3109\/10428194.2014.928936","journal-title":"Leuk Lymphoma"},{"key":"4645_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2169\/internalmedicine.5027-20","volume":"60","author":"H Kobe","year":"2021","unstructured":"Kobe H, Ito A, Hayata H, Nishimura K, Ueda Y, Ishida T (2021) Mycophenolate mofetil-induced diffuse large B-cell lymphoma in which a solitary lung nodule remitted spontaneously. Intern Med 60:131\u2013136. https:\/\/doi.org\/10.2169\/internalmedicine.5027-20","journal-title":"Intern Med"},{"key":"4645_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.39480","volume":"68","author":"JA Singh","year":"2016","unstructured":"Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC et al (2016) 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol 68:1\u201326. https:\/\/doi.org\/10.1002\/art.39480","journal-title":"Arthritis Rheumatol"},{"key":"4645_CR6","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.2169\/internalmedicine.0875-18","volume":"57","author":"M Hagihara","year":"2018","unstructured":"Hagihara M, Mese T, Ohara S, Hua J, Ide S, Inoue M (2018) Methotrexate-associated intravascular large B-cell lymphoma in a patient with rheumatoid arthritis: a very rare case. Intern Med 57:3001\u20133005. https:\/\/doi.org\/10.2169\/internalmedicine.0875-18","journal-title":"Intern Med"},{"key":"4645_CR7","doi-asserted-by":"publisher","first-page":"7957","DOI":"10.3892\/ol.2017.7232","volume":"14","author":"I Hus","year":"2017","unstructured":"Hus I, Bojarska-Junak A, Kami\u0144ska M, Dobrzy\u0144ska-Rutkowska A, Szatan K, Szymczyk A et al (2017) Imbalance in circulatory iNKT, Th17 and T regulatory cell frequencies in patients with B-cell non-Hodgkin\u2019s lymphoma. Oncol Lett 14:7957\u20137964. https:\/\/doi.org\/10.3892\/ol.2017.7232","journal-title":"Oncol Lett"},{"key":"4645_CR8","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/rheumatology\/kex002","volume":"56","author":"S Saito","year":"2017","unstructured":"Saito S, Kaneko Y, Yamaoka K, Tokuhira M, Takeuchi T (2017) Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate. Rheumatology (Oxford) 56:940\u2013946. https:\/\/doi.org\/10.1093\/rheumatology\/kex002","journal-title":"Rheumatology (Oxford)"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04645-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-021-04645-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04645-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T01:54:52Z","timestamp":1634090092000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-021-04645-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,22]]},"references-count":8,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["4645"],"URL":"https:\/\/doi.org\/10.1007\/s00277-021-04645-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,22]]},"assertion":[{"value":"10 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent for the publication of this article was obtained from the patient on 25th, May, 2021.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"J.K. has received research funding from Bristol\u2013Myers Squibb, Sysmex, Celgene, Ono Pharmaceutical, Otsuka Pharmaceutical, Sanofi, Kyowa Kirin, Sanofi, Chugai Pharmaceutical, Eisai, Dainippon Sumitomo Pharma, Nippon Shinyaku, Takeda, Shionogi, Asahi Kasei, Daiichi Sankyo, MSD, Taiho Pharmaceutical, and Abbvie; has received honoraria from Bristol\u2013Myers Squibb, Janssen Pharmaceutical K.K, Celgene Corporation, Ono Pharmaceutical, Takeda, Sanofi, Kyowa Kirin, Chugai Pharmaceutical, Eisai, Astellas Pharma, Nippon Shinyaku, Dainippon Sumitomo Pharma, Symbio, Daiichi Sankyo, Fujimoto Pharmaceutical, Abbvie, and Otsuka Pharmaceutical; and is a consultant of Janssen Pharmaceutical K.K, Celgene, Bristol\u2013Myers Squibb, Sanofi, and Abbvie.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}